HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuo Suenaga Selected Research

Yasuo Suenaga Research Topics

Disease

8Rheumatoid Arthritis
01/2022 - 02/2013
5Infections
01/2022 - 01/2013
2Rheumatic Diseases (Rheumatism)
04/2018 - 06/2015
1Disease Progression
01/2022
1Pneumococcal Pneumonia
01/2017
1Pneumonia (Pneumonitis)
01/2017
1Arthritis (Polyarthritis)
01/2015
1Interstitial Lung Diseases (Interstitial Lung Disease)
11/2014
1Autoimmune Diseases (Autoimmune Disease)
01/2013

Drug/Important Bio-Agent (IBA)

323-valent pneumococcal capsular polysaccharide vaccineIBA
01/2017 - 06/2015
3Polysaccharides (Glycans)IBA
12/2015 - 06/2015
2Biological ProductsIBA
01/2022 - 04/2018
2VaccinesIBA
01/2017 - 12/2015
2Methotrexate (Mexate)FDA LinkGeneric
12/2015 - 01/2015
2Peptides (Polypeptides)IBA
01/2015 - 02/2013
2Adrenal Cortex Hormones (Corticosteroids)IBA
11/2014 - 01/2013
1Prednisolone (Predate)FDA LinkGeneric
01/2022
1SteroidsIBA
01/2022
11- hydroxy- 5,8- bis(2- ((2- hydroxyethyl)amino)ethylamino)- 9,10- anthracenedioneIBA
04/2018
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
01/2017
1Abatacept (Orencia)FDA Link
12/2015
1golimumabFDA Link
12/2015
1Tacrolimus (Prograf)FDA LinkGeneric
06/2015
1Biomarkers (Surrogate Marker)IBA
02/2013
1Interleukin-6 (Interleukin 6)IBA
02/2013
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2013
1GlucocorticoidsIBA
01/2013

Therapy/Procedure

2Therapeutics
01/2022 - 01/2013
1Biological Therapy
01/2022